Warner Chilcott Reports Operating Results for the Quarter Ended Septembe...(2007 Full Year Financial Guidance ...),Health
2007 Full Year Financial Guidance
(U.S. dollars in millions, except per share)
Previous Guidance Revised Guidance
August 2007 November 2007
Total Revenue $870 to $890 $870 to $890(1)
Gross margin as a % of
revenue 79% to 80% 79% to 80%
SG&A Expenses:
Selling $87 to $90 $87 to $90
A&P $82 to $85 $82 to $85
G&A $81 to $84 $93 to $96
Total SG&A Expense $250 to $259 $262 to $271
Total R&D $54 to $57 $54 to $57(2)
Total income tax provision 6% to 7% of EBTA 6% of EBTA(3)
GAAP Net Income $16 to $21 $12 to $17
Adjusted CNI $250 to $255 $258 to $263(4)
Adjusted CNI per share $1.00 to $1.02 $1.03 to $1.05(5)
(1) Total revenue is anticipated to be at the higher end of the guidance
range.
(2) Total R&D consists of internal R&D anticipated to be in the range of
$40 to $43 million, $10 million milestone
payment to LEO Pharma and $4 million payment to Paratek.
(3) A proxy for the total 2007 tax provision is estimated to be 6% of
earnings before taxes and book amortization (''EBTA'').
(4) A reconciliation of GAAP net income to adjusted cash net income adds
back the expected after tax impact of amortization of intangibles
($208.5M), the expected after tax impact of deferred financing fees
($11.9M) and the expenses associated with the settlements of certain
legal actions related to the OVCON 35 litigation ($26.0M) recorded
during the nine mon
'/>"/>
| SOURCE Warner Chilcott Limited Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
2. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |